Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CNMAU-8 by Clene for Relapsing Multiple Sclerosis (RMS): Likelihood of Approval
CNMAU-8 is under clinical development by Clene and currently in Phase III for Relapsing Multiple Sclerosis (RMS). According to GlobalData,...
CNMAU-8 by Clene for Primary Progressive Multiple Sclerosis (PPMS): Likelihood of Approval
CNMAU-8 is under clinical development by Clene and currently in Phase III for Primary Progressive Multiple Sclerosis (PPMS). According to...
CNMAU-8 by Clene for Secondary Progressive Multiple Sclerosis (SPMS): Likelihood of Approval
CNMAU-8 is under clinical development by Clene and currently in Phase III for Secondary Progressive Multiple Sclerosis (SPMS). According to...